TECX insider trading

Healthcare

Tectonic Therapeutic, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
90
Last 90 days
10
Buys / sells
23% / 13%
Market cap
$399.59M

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Company website: tectonictx.com

TECX insider activity at a glance

FilingIQ tracks 90 insider transactions for TECX in filings since Jun 24, 2024. The most recent transaction is dated Sep 30, 2026.

Across the full history, 21 open-market purchases and 12 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TECX insider trades is 60.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest TECX Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for TECX?
FilingIQ tracks 90 Form 4 insider transactions for TECX (Tectonic Therapeutic, Inc.), covering filings from Jun 24, 2024 onwards. 10 of those are dated within the last 90 days.
Are TECX insiders net buyers or net sellers?
Across the full Form 4 history for TECX, 21 transactions (23%) were open-market purchases and 12 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TECX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is TECX in?
Tectonic Therapeutic, Inc. (TECX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $399.59M.

Methodology & sources

Every TECX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.